{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:46:38Z","timestamp":1770986798462,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,23]]},"DOI":"10.7759\/cureus.23427","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T15:51:01Z","timestamp":1648050661000},"source":"Crossref","is-referenced-by-count":3,"title":["Acute Kidney Injury Related to Intoxication From Synthetic Cannabis: Don\u2019t You Know That You\u2019re Toxic?"],"prefix":"10.7759","author":[{"given":"Brett","family":"Curtis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bishow","family":"Mahat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Macklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Mihalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allie H","family":"Dakroub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.08.005","article-title":"Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications","volume":"144","author":"Castaneto MS","year":"2014","unstructured":"Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014, 144:12-41. 10.1016\/j.drugalcdep.2014.08.005","journal-title":"Drug Alcohol Depend"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6527a2","article-title":"Acute poisonings from synthetic cannabinoids - 50 U.S. Toxicology Investigators Consortium Registry sites, 2010-2015","volume":"65","author":"Riederer AM","year":"2016","unstructured":"Riederer AM, Campleman SL, Carlson RG, Boyer EW, Manini AF, Wax PM, Brent JA. Acute poisonings from synthetic cannabinoids - 50 U.S. Toxicology Investigators Consortium Registry sites, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016, 65:692-5. 10.15585\/mmwr.mm6527a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref3","unstructured":"National Institute on Drug Abuse (NIDA). Synthetic cannabinoids (K2\/spice) unpredictable danger. (2017). Accessed: January 24, 2021: https:\/\/www.drugabuse.gov\/drug-topics\/trends-statistics\/infographics\/synthetic-cannabinoids-k2spice-unpredictable-danger."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05690612","article-title":"AKI associated with synthetic cannabinoids: a case series","volume":"8","author":"Bhanushali GK","year":"2013","unstructured":"Bhanushali GK, Jain G, Fatima H, Leisch LJ, Thornley-Brown D. AKI associated with synthetic cannabinoids: a case series. Clin J Am Soc Nephrol. 2013, 8:523-6. 10.2215\/CJN.05690612","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref5","article-title":"Acute kidney injury associated with synthetic cannabinoid use--multiple states, 2012","volume":"62","year":"2013","unstructured":"Acute kidney injury associated with synthetic cannabinoid use--multiple states, 2012. MMWR Morb Mortal Wkly Rep. 2013, 62.93-8.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03220807","article-title":"Toxic alcohol ingestions: clinical features, diagnosis, and management","volume":"3","author":"Kraut JA","year":"2008","unstructured":"Kraut JA, Kurtz I. Toxic alcohol ingestions: clinical features, diagnosis, and management. Clin J Am Soc Nephrol. 2008, 3:208-25. 10.2215\/CJN.03220807","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref7","article-title":"Clinical inquiries. How much can exercise raise creatine kinase level--and does it matter?","volume":"57","author":"Latham J","year":"2008","unstructured":"Latham J, Campbell D, Nichols W, Mott T. Clinical inquiries. How much can exercise raise creatine kinase level--and does it matter?. J Fam Pract. 2008, 57:545-7.","journal-title":"J Fam Pract"},{"key":"ref8","article-title":"Chapter 5: Acute kidney injury","author":"United States Renal Data System","year":"2018","unstructured":"United States Renal Data System. Chapter 5: Acute kidney injury. 2018 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2018. 1:99-124."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2015.11929313","article-title":"Synthetic cannabinoids and acute kidney injury","volume":"28","author":"Srisung W","year":"2015","unstructured":"Srisung W, Jamal F, Prabhakar S. Synthetic cannabinoids and acute kidney injury. Proc (Bayl Univ Med Cent). 2015, 28:475-7. 10.1080\/08998280.2015.11929313","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107810","article-title":"Regional trends in suspected synthetic cannabinoid exposure from January 2016 to September 2019 in the United States","volume":"207","author":"Roehler DR","year":"2020","unstructured":"Roehler DR, Hoots BE, Vivolo-Kantor AM. Regional trends in suspected synthetic cannabinoid exposure from January 2016 to September 2019 in the United States. Drug Alcohol Depend. 2020, 207:107810. 10.1016\/j.drugalcdep.2019.107810","journal-title":"Drug Alcohol Depend"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-020-02693-7","article-title":"Designer drugs: mechanism of action and adverse effects","volume":"94","author":"Luethi D","year":"2020","unstructured":"Luethi D, Liechti ME. Designer drugs: mechanism of action and adverse effects. Arch Toxicol. 2020, 94:1085-133. 10.1007\/s00204-020-02693-7","journal-title":"Arch Toxicol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2012.03.007","article-title":"A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010","volume":"60","author":"Hoyte CO","year":"2012","unstructured":"Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med. 2012, 60:435-8. 10.1016\/j.annemergmed.2012.03.007","journal-title":"Ann Emerg Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.07.011","article-title":"A survey study to characterize use of Spice products (synthetic cannabinoids)","volume":"120","author":"Vandrey R","year":"2012","unstructured":"Vandrey R, Dunn KE, Fry JA, Girling ER. A survey study to characterize use of Spice products (synthetic cannabinoids). Drug Alcohol Depend. 2012, 120:238-41. 10.1016\/j.drugalcdep.2011.07.011","journal-title":"Drug Alcohol Depend"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/1947-2714.185038","article-title":"Acute rhabdomyolysis following synthetic cannabinoid ingestion","volume":"8","author":"Adedinsewo DA","year":"2016","unstructured":"Adedinsewo DA, Odewole O, Todd T. Acute rhabdomyolysis following synthetic cannabinoid ingestion. N Am J Med Sci. 2016, 8:256-8. 10.4103\/1947-2714.185038","journal-title":"N Am J Med Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/16-160","article-title":"Spice-y kidney failure: a case report and systematic review of acute kidney injury attributable to the use of synthetic cannabis","volume":"21","author":"Zarifi C","year":"2017","unstructured":"Zarifi C, Vyas S. Spice-y kidney failure: a case report and systematic review of acute kidney injury attributable to the use of synthetic cannabis. Perm J. 2017, 21:10.7812\/TPP\/16-160","journal-title":"Perm J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-021-01847-w","article-title":"Gastrointestinal manifestations of synthetic cannabinoids: a retrospective cohort study","volume":"21","author":"Hakimian D","year":"2021","unstructured":"Hakimian D, Benson AA, Khoury T, et al.. Gastrointestinal manifestations of synthetic cannabinoids: a retrospective cohort study. BMC Gastroenterol. 2021, 21:274. 10.1186\/s12876-021-01847-w","journal-title":"BMC Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1336","article-title":"Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy","volume":"59","author":"Barutta F","year":"2010","unstructured":"Barutta F, Corbelli A, Mastrocola R, et al.. Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy. Diabetes. 2010, 59:1046-54. 10.2337\/db09-1336","journal-title":"Diabetes"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1423","article-title":"Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db\/db mice","volume":"153","author":"Nam DH","year":"2012","unstructured":"Nam DH, Lee MH, Kim JE, et al.. Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db\/db mice. Endocrinology. 2012, 153:1387-96. 10.1210\/en.2011-1423","journal-title":"Endocrinology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.8516","article-title":"Critical illness secondary to synthetic cannabinoid ingestion","volume":"3","author":"Kourouni I","year":"2020","unstructured":"Kourouni I, Mourad B, Khouli H, Shapiro JM, Mathew JP. Critical illness secondary to synthetic cannabinoid ingestion. JAMA Netw Open. 2020, 3:e208516. 10.1001\/jamanetworkopen.2020.8516","journal-title":"JAMA Netw Open"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca SG","year":"2012","unstructured":"Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012, 81:442-8. 10.1038\/ki.2011.379","journal-title":"Kidney Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/72757-acute-kidney-injury-related-to-intoxication-from-synthetic-cannabis-dont-you-know-that-youre-toxic","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:07Z","timestamp":1707507787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/72757-acute-kidney-injury-related-to-intoxication-from-synthetic-cannabis-dont-you-know-that-youre-toxic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,23]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.23427","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,23]]}}}